Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

The Health Secretary will set out a 10-year plan including proposals to bring down the cost of drugs such as Wegovy and ...

Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Mounjaro users in the UK have to jump through quite a few hoops to get their hands on the weight-loss drug. You might think ...

Patients prescribed Mounjaro - dubbed the 'King Kong' of injections due to its potency - took to social media concerned they ...

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

If you’ve been waiting for the chance for weight loss injections to drop in price, there are more options turning up to ...

Hims & Hers thrives with telehealth growth, strong subscriber base, and expanding products, despite challenges like ...